🔊 From imaging to sonar, sound has long been a powerful tool. Now, scientists are using ultrasound to tackle #pain, #addiction, and even #cancer.
Wynn Legon shares why the world is finally paying attention.
Follow Pocket Science today 🚀 ⤵️
https://t.co/3Jsoh09v5k
Catch Dr. Legon on the new episode of Pocket Science, @FralinBiomed's new podcast! The episode dives into focused ultrasound & our chronic pain research. Listen on Spotify, Apple Podcasts, Youtube, & more!
https://t.co/0NqZFFRQqS
What is low-intensity focused ultrasound (LIFU) for human neuromodulation? It was a privilege to help write this primer with my mentor @WynnLegonLab , out now @MethodsPrimers You can read the full article here https://t.co/mpWzdNjfNu. @FralinBiomed@virginia_tech@vtcsom
Low-intensity focused ultrasound (LIFU) is a potentially transformative neuromodulation technique that offers millimeter precision and adjustable focal lengths to target small and deep human brain circuitry.
Read the full primer below on @MethodsPrimers:
https://t.co/Ut1Yl61tym
A big congrats to the Legon Lab's PhD student Gabe Isaac and junior Aditya Kapoor on winning 1st and 2nd place in the Lightning Talk Competition at the DC Society for Neuroscience conference this past weekend! @FralinBiomed@VTNeuro
New study out from @WynnLegonLab in collaboration with @KhalsaLab and @Ch_Verdonk. low-intensity focused ultrasound (LIFU) to the insula differentially modulates the heartbeat-evoked potential: a proof-of-concept study. Link to the full article here: https://t.co/YmLqP7o0sV
Interested in working in research?
Our collaborator is hiring a full-time research technician. Clinical experience preferred, strong interpersonal and organizational skills required.
Work directly with patients to administer eTMS therapy.
Starting pay 55k, benefits, 401k.
“Noninvasive neuromodulation of subregions of the human insula differentially affect pain processing and heart-rate variability: a within-subjects pseudo-randomized trial” by @WynnLegonLab is available #OpenAccess in the July issue of #PAIN https://t.co/FtlDhO0KU6
@WynnLegonLab find that noninvasive modulation of insula subregions affects pain ratings, brain physiology related to pain, and metrics of autonomic/cardiovascular activity including heart-rate variability. Learn more in #PAIN https://t.co/FtlDhO0KU6
Now in #PAIN: “Noninvasive neuromodulation of subregions of the human insula differentially affect pain processing and heart-rate variability: a within-subjects pseudo-randomized trial” by @WynnLegonLab https://t.co/FtlDhO0KU6
Virginia Tech takes a leap forward in medical innovation! 🚀 Honored to be designated as a Center of Excellence by @fusfoundation, recognizing our leading role in advancing non-invasive medical treatments. #FocusedUltrasound#Innovation https://t.co/3FfNGfSCJa
Results from two clinical trials investigating low-intensity focused ultrasound (LIFU) for the treatment of pain have been published. In both trials, the teams from @WynnLegonLab at @FralinBiomed showed that LIFU could be an effective method for noninvasive neuromodulation of pain. https://t.co/U9FqOgMG9G
Please join brainSTIM for the following talk next Monday, 4/8 at 3 PM with Wynn Legon, Ph.D. (Virginia Tech Carilion School of Medicine)!
"Low-intensity focused ultrasound for human neuromodulation applications”
Brain Awareness Week has come and gone, but what a cerebral celebration it was 🥳🧠
Nearly 200 people packed in for Brain School which included programming around #brain#science and its role in helping people lead healthier lives.
Learn more! ⤵️
https://t.co/b8qXzD9grK